| Title |
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
|
|---|---|
| Published in |
Archives of Pathology & Laboratory Medicine, October 2013
|
| DOI | 10.5858/arpa.2013-0953-sa |
| Pubmed ID | |
| Authors |
Antonio C. Wolff, M. Elizabeth H. Hammond, David G. Hicks, Mitch Dowsett, Lisa M. McShane, Kimberly H. Allison, Donald C. Allred, John M.S. Bartlett, Michael Bilous, Patrick Fitzgibbons, Wedad Hanna, Robert B. Jenkins, Pamela B. Mangu, Soonmyung Paik, Edith A. Perez, Michael F. Press, Patricia A. Spears, Gail H. Vance, Giuseppe Viale, Daniel F. Hayes |
X Demographics
The data shown below were collected from the profiles of 32 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 9 | 28% |
| Spain | 5 | 16% |
| Indonesia | 1 | 3% |
| Peru | 1 | 3% |
| Saudi Arabia | 1 | 3% |
| Ecuador | 1 | 3% |
| India | 1 | 3% |
| Australia | 1 | 3% |
| Unknown | 12 | 38% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 22 | 69% |
| Practitioners (doctors, other healthcare professionals) | 6 | 19% |
| Science communicators (journalists, bloggers, editors) | 3 | 9% |
| Scientists | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 1,324 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Portugal | 3 | <1% |
| Japan | 3 | <1% |
| Brazil | 3 | <1% |
| Russia | 2 | <1% |
| United Kingdom | 2 | <1% |
| Austria | 2 | <1% |
| France | 1 | <1% |
| Ireland | 1 | <1% |
| Turkey | 1 | <1% |
| Other | 12 | <1% |
| Unknown | 1294 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 192 | 15% |
| Researcher | 180 | 14% |
| Student > Master | 142 | 11% |
| Student > Bachelor | 130 | 10% |
| Other | 124 | 9% |
| Other | 305 | 23% |
| Unknown | 251 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 522 | 39% |
| Biochemistry, Genetics and Molecular Biology | 164 | 12% |
| Agricultural and Biological Sciences | 135 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 43 | 3% |
| Engineering | 37 | 3% |
| Other | 127 | 10% |
| Unknown | 296 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 464. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 May 2022.
All research outputs
#59,545
of 26,017,215 outputs
Outputs from Archives of Pathology & Laboratory Medicine
#8
of 2,789 outputs
Outputs of similar age
#347
of 226,468 outputs
Outputs of similar age from Archives of Pathology & Laboratory Medicine
#1
of 30 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,789 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 18.1. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 226,468 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 30 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.